Royalty Pharma plc Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2019 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Royalty Pharma plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q1 2022.
  • Royalty Pharma plc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2022 was $700K, a 22.2% decline year-over-year.
  • Royalty Pharma plc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2022 was $2.9M.
  • Royalty Pharma plc annual Share-based Payment Arrangement, Expense for 2021 was $3.1M, a 45.6% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $2.9M $700K -$200K -22.2% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $3.1M $600K Oct 1, 2021 Dec 31, 2021 10-K 2022-02-15
Q3 2021 $700K -$300K -30% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $900K -$2.8M -75.7% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $900K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $3.7M +$3.7M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.